SKN | Parabilis Medicines Expands IPO Offering by 33% Ahead of Planned $600 Million Market Debut
Clinical-stage cancer biotechnology company Parabilis Medicines has increased the size of its planned initial public offering (IPO), signaling growing confidence in investor demand ahead...
SKN | Cerebras Systems Surges as AI Infrastructure Demand Fuels Investor Optimism
Cerebras Systems Inc. (NASDAQ: CBRS) attracted significant market attention after its shares climbed more than 18% in a single trading session, reflecting growing investor...
SKN | Eloxx Pharmaceuticals, Inc. Common Stock IPO Faces Market Scrutiny Amid Revised Offering Structure
Lead Paragraph
Eloxx Pharmaceuticals, Inc. is advancing toward its IPO market debut with revised offering terms and a reduced share count, reflecting a cautious approach...
SKN | Lannister Mining Corp. IPO Seeks Capital Market Entry as Offering Is Trimmed Ahead of Debut
Lead Paragraph
Lannister Mining Corp. is moving toward its IPO market debut with revised offering terms and a reduced share count, signaling a more disciplined...
SKN | Singapore-Based Star Integratia Seeks $29 Million Nasdaq IPO to Expand Digital Geomancy Platform
Star Integratia, a Singapore-based provider of geomancy and divination services, has filed with the U.S. Securities and Exchange Commission to raise up to $29...